| Literature DB >> 24179471 |
Abstract
Mobilization of peripheral blood stem cells (PBSC) in healthy volunteers with granulocyte colony-stimulating factor (G-CSF) is currently carried out at many institutions worldwide. This report presents the experience of the Dresden center regarding donor evaluation and mobilization schedule. Data regarding efficacy, short- and long-term safety of G-CSF treatment gained from 8290 PBSC collections in healthy donors are outlined. These results are discussed against the background of the available evidence from the literature. Although established as a standard procedure, G-CSF application to allogeneic donors will always be a very delicate procedure and requires the utmost commitment of all staff involved to ensure maximum donor safety.Entities:
Keywords: CD34+ cells; Donors; G-CSF; Hematopoietic stem cells; Leukapheresis product
Year: 2013 PMID: 24179471 PMCID: PMC3776391 DOI: 10.1159/000354196
Source DB: PubMed Journal: Transfus Med Hemother ISSN: 1660-3796 Impact factor: 3.747